2022 2021/  2020 /  2019 /  2018 / 2017 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008
11.23.2022- Astrotech Announces Reverse Stock Split

Astrotech Corporation (Nasdaq: ASTC) a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology, today announced that it has filed a third amendment to its Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio of 1-for-30 (the “Charter Amendment”).

11.22.2022- Astrotech Corporation Announces Advancement in Detection of Lung Infection the BreathTest-1000 

Astrotech Corporation (Nasdaq: ASTC) subsidiary, BreathTech Corporation (“BreathTech”), announced today that, based on analysis of data from testing of breath samples procured during our library development, the BreathTest-1000TM lung disease screening instrument can clearly distinguish between infected and healthy breath samples.

11.14.2022- Astrotech Launches the AgLAB-1000-D2 Maximum Value Processing Control System

Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) subsidiary, AgLAB, Inc. (AgLAB), today announced the launch of the AgLAB-1000-D2™ and the Maximum Value Processing™ (D2-MVP) control system.

11.10.2022- Astrotech Reports First Quarter of Fiscal Year 2023 Financial Results

Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the first quarter of fiscal year 2023, which ended September 30, 2022.

09.14.2022- Astrotech Reports Fiscal Year 2022 Financial Results

Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the fiscal year ended June 30, 2022.

08.24.2022- Astrotech Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals

Astrotech Corporation (Nasdaq: ASTC) announced its plans to hold its fiscal year 2022 annual meeting of stockholders stockholders (the “2022 Annual Meeting”) on Tuesday, November 15, 2022.

06.23.2022- Astrotech Subsidiary and Cleveland Clinic Expand Breath Analysis Study to Detect Multiple Diseases

Astrotech Corporation (Nasdaq: ASTC) subsidiary, BreathTech Corporation, announced today that it has amended its Joint Development and Option Agreement with Cleveland Clinic to include additional areas of focus.

05.12.2022- Astrotech Reports Third Quarter of Fiscal Year 2022 Financial Results

Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2022, which ended March 31, 2022.

04.05.2022- Astrotech Reports Resignation and Hire of its New Chief Financial Officer

Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) appointed Jaime Hinojosa, 40, as Chief Financial Officer, Treasurer and Secretary of the Company, effective as of April 15, 2022. Mr. Hinojosa will perform the functions of the Company’s principal financial officer.

02.11.2022- Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results

Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021.

02.02.2022- Astrotech Subsidiary BreathTech Hires Dr. Karim Sirgi as its Chief Science Officer

Astrotech Corporation (Nasdaq: ASTC) has hired Dr. Karim Sirgi, MD, MBA and FCAP as the Chief Science Officer of subsidiary BreathTech Corporation in preparation of human trials with Cleveland Clinic for its BreathTest-1000™ to help in the battle against COVID-19 and its variants.

01.06.2022- Astrotech Announces Date for Fiscal Year 2021 Annual Meeting and Deadlines for Stockholder proposals

Astrotech Corporation (Nasdaq: ASTC) (the “Company”) announced its plans to hold its fiscal year 2021 annual meeting of stockholders (the “2021 Annual Meeting”) on Friday, March 25, 2022. The 2021 Annual Meeting will be held at 9:00 A.M. Central Time. Current plans are for the meeting to be in person in Austin, Texas at the AT&T Hotel and Conference Center.